A detailed analysis of blood samples from Ebola patients in Sierra Leone is providing clues about the progression of the effects of the Ebola virus in patients and potential treatment pathways. The findings point to a critical role for a molecular pathway that relies on the common nutrient choline, as well as the importance of cellular bodies known as microvesicles.
This National Ebola Training and Education Center course discusses the assessment, management, and placement of persons suspected to have Ebola and Other Special Pathogens.
.This course facilitates learners to describe pathogen-related factors that may warrant treatment in a biocontainment unit and to distinguish between concepts of infectious, communicable, and hazardous as they relate to Ebola and other special pathogens of concern. Participants will also be able to describe the clinical presentation of selected special pathogens from the two broad categories: viral hemorrhagic fevers and the highly pathogenic respiratory viruses.
A team of researchers have discovered the interaction between an Ebola virus protein and a protein in human cells that may be an important key to unlocking the pathway of replication of the killer disease in human hosts.
A human protein called RBBP6 helps fight the Ebola virus by interfering with its replication cycle, and a small molecule drug that mimics the function of this protein could one day be an effective therapy against the deadly disease.
Scientists in Japan have obtained a near-atomic resolution model of an important Ebola virus protein.
The factors that determine who is susceptible to Ebola infection and who is not are still a mystery. Researchers are trying to find out how malarial infections impact people exposed to Ebola virus.
Researchers have for the first time imaged the structure of a central component of the Ebola virus at near-atomic resolution. This structure allows the virus to replicate its deadly payload.